Joshua Prey

668 total citations
22 papers, 550 citations indexed

About

Joshua Prey is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joshua Prey has authored 22 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joshua Prey's work include Cancer therapeutics and mechanisms (7 papers), Selenium in Biological Systems (3 papers) and Lung Cancer Research Studies (3 papers). Joshua Prey is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Selenium in Biological Systems (3 papers) and Lung Cancer Research Studies (3 papers). Joshua Prey collaborates with scholars based in United States, Italy and Canada. Joshua Prey's co-authors include Gerald J. Fetterly, Lakshmi Pendyala, Jonathan B. Fitzgerald, Jaeyeon Kim, Eliel Bayever, Natarajan Raghunand, Daryl C. Drummond, Stephan G. Klinz, Ramesh K. Ramanathan and Jasgit C. Sachdev and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Joshua Prey

21 papers receiving 542 citations

Peers

Joshua Prey
May Lin Yap Australia
Ana Miranda Portugal
Miaojuan Qiu China
Can Huang China
Lifeng Wang China
Qiang Tong China
May Lin Yap Australia
Joshua Prey
Citations per year, relative to Joshua Prey Joshua Prey (= 1×) peers May Lin Yap

Countries citing papers authored by Joshua Prey

Since Specialization
Citations

This map shows the geographic impact of Joshua Prey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Prey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Prey more than expected).

Fields of papers citing papers by Joshua Prey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Prey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Prey. The network helps show where Joshua Prey may publish in the future.

Co-authorship network of co-authors of Joshua Prey

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Prey. A scholar is included among the top collaborators of Joshua Prey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Prey. Joshua Prey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sexton, Sandra, et al.. (2025). Preclinical experience with cisplatin, gemcitabine, and doxorubicin in pulmonary suffusion. JTCVS Open. 24. 484–495.
2.
3.
Ramanathan, Ramesh K., Ronald L. Korn, Natarajan Raghunand, et al.. (2017). Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study. Clinical Cancer Research. 23(14). 3638–3648. 134 indexed citations
4.
Clarke, Jennifer, Annette M. Molinaro, Jane Rabbitt, et al.. (2017). A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemotherapy and Pharmacology. 79(3). 603–610. 38 indexed citations
5.
Hylander, Bonnie L., Arindam Sen, Sarah H. Beachy, et al.. (2015). Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model. Journal of Controlled Release. 217. 160–169. 22 indexed citations
6.
Adelaiye‐Ogala, Remi, Eric Ciamporcero, Kiersten Marie Miles, et al.. (2014). Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications. Molecular Cancer Therapeutics. 14(2). 513–522. 56 indexed citations
7.
Tornatore, Kathleen M., Calvin J. Meaney, Gregory E. Wilding, et al.. (2014). Influence of Sex and Race on Mycophenolic Acid Pharmacokinetics in Stable African American and Caucasian Renal Transplant Recipients. Clinical Pharmacokinetics. 54(4). 423–434. 35 indexed citations
8.
Ramanathan, Ramesh K., Ronald L. Korn, Jasgit C. Sachdev, et al.. (2014). Abstract CT224: Pilot study in patients with advanced solid tumors to evaluate feasibility of ferumoxytol (FMX) as tumor imaging agent prior to MM-398, a nanoliposomal irinotecan (nal-IRI). Cancer Research. 74(19_Supplement). CT224–CT224. 15 indexed citations
9.
Ramanathan, Ramesh K., Ron Korn, Jasgit C. Sachdev, et al.. (2014). 261 Lesion characterization with ferumoxytol MRI in patients with advanced solid tumors and correlation with treatment response to MM-398, nanoliposomal irinotecan (nal-IRI). European Journal of Cancer. 50. 87–87. 6 indexed citations
10.
Lin, Mei‐Hui, Lili Tian, Michael P. Murphy, et al.. (2010). Aflibercept Exerts Antivascular Effects and Enhances Levels of Anthracycline Chemotherapy In vivo in Human Acute Myeloid Leukemia Models. Molecular Cancer Therapeutics. 9(10). 2737–2751. 18 indexed citations
11.
Javle, Milind, Gary Yang, Gregory E. Wilding, et al.. (2009). Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis. Cancer Investigation. 27(2). 193–200. 14 indexed citations
12.
Bailey, Dennis B., Kenneth M. Rassnick, Joshua Prey, & Nathan L. Dykes. (2009). Evaluation of serum iohexol clearance for use in predicting carboplatin clearance in cats. American Journal of Veterinary Research. 70(9). 1135–1140. 10 indexed citations
13.
Fetterly, Gerald J., William E. Brady, Charles LeVea, et al.. (2009). A phase I pharmacokinetic (PK) study of vorinostat (V) in combination with irinotecan (I), 5-fluorouracil (5FU), and leucovorin (FOLFIRI) in advanced upper gastrointestinal cancers (AGC). Journal of Clinical Oncology. 27(15_suppl). e15540–e15540. 10 indexed citations
14.
Fakih, Marwan, Lakshmi Pendyala, William E. Brady, et al.. (2007). A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors. Cancer Chemotherapy and Pharmacology. 62(3). 499–508. 31 indexed citations
15.
Azrak, Rami G., Shousong Cao, Lakshmi Pendyala, et al.. (2006). Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochemical Pharmacology. 73(9). 1280–1287. 25 indexed citations
16.
Smith, Peter R., Marwan Fakih, Lakshmi Pendyala, et al.. (2006). OIV-A-1Pharmacokinetics and dose optimization of selenomethionine (SLM) as an adjunct to irinotecan (CPT-11) therapy. Clinical Pharmacology & Therapeutics. 79(2). P31–P31. 1 indexed citations
17.
Fakih, Marwan, Lakshmi Pendyala, Patrick F. Smith, et al.. (2006). A phase I and pharmacokinetic study of fixed-dose selenomethionine and irinotecan in solid tumors.. Clinical Cancer Research. 12(4). 1237–1244. 31 indexed citations
18.
Song, Liguo, Joshua Prey, Jun Xue, et al.. (2005). Pharmacokinetic measurements of IDN 5390 using electrospray ionization tandem mass spectrometry: structure characterization and quantification in dog plasma. Rapid Communications in Mass Spectrometry. 19(24). 3617–3625. 9 indexed citations
19.
Hector, Suzanne, Carl W. Porter, Debora L. Kramer, et al.. (2004). Polyamine catabolism in platinum drug action: Interactions between oxaliplatin and the polyamine analogue N1,N11-diethylnorspermine at the level of spermidine/spermine N1-acetyltransferase. Molecular Cancer Therapeutics. 3(7). 813–822. 46 indexed citations
20.
Azrak, Rami G., Lakshmi Pendyala, Farukh A. Durrani, et al.. (2004). 613 Plasma and tissue distribution of selenium after 5-methylselenocysteine (MSC) or seleno-L-methionine (SLM) in mice bearing human tumor xenografts. European Journal of Cancer Supplements. 2(8). 185–186. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by May Lin Yap Breakdown of academic impact, for papers by Ana Miranda Breakdown of academic impact, for papers by Miaojuan Qiu Breakdown of academic impact, for papers by Can Huang Breakdown of academic impact, for papers by Lifeng Wang Breakdown of academic impact, for papers by Qiang Tong
Rankless by CCL
2026